This inventor holds 5 USPTO granted patents and 6 published patent applications and 4 EPO patents. Top assignees: Deutsches Krebsforschungszentrum, Bayer Aktiengesellschaft, Bayer Pharma Aktiengesellschaft. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
5 out of 159 
4 out of 12,268 
4 out of 387 
Years Active: 2022-2026
Title: Rafael Carretero: Pioneer in Cancer Treatment Innovations
Introduction
Rafael Carretero is an esteemed inventor based in Heidelberg, Germany, known for his remarkable contributions to the field of pharmaceuticals. With a total of four patents to his name, he has focused his research and innovations primarily on developing compounds for cancer treatment.
Latest Patents
Among Carretero’s notable patents are two significant inventions that address cancer therapy through unique chemical compounds. The first is centered around "2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides", which encompasses a series of compounds formulated to tackle various cancer types. This invention includes methods for synthesizing the compounds, as well as their pharmaceutical applications for treating and preventing conditions linked with dysregulated immune responses, specifically those associated with aberrant AHR signaling.
The second patent focuses on "3-oxo-6-heteroaryl-2-phenyl-2,3-dihydropyridazine-4-carboxamides". Similarly, this innovation covers a range of compounds effective against cancer and related disorders. Carretero’s work outlines not only the preparation techniques but also the pharmaceutical compositions that integrate these compounds and their potential as active agents in cancer therapeutics.
Career Highlights
Rafael Carretero has made significant strides in the pharmaceutical industry throughout his career. He has worked with renowned companies such as Bayer Aktiengesellschaft and Bayer Pharma Aktiengesellschaft. His tenure at these institutions has allowed him to develop his innovative ideas into patentable inventions, significantly impacting cancer treatment options.
Collaborations
Throughout his career, Carretero has collaborated with talented professionals in the field, including Ilona Gutcher and Lars Röse. These partnerships have played a vital role in advancing his research and augmenting the development of his pharmaceutical compounds.
Conclusion
Rafael Carretero’s innovative work in cancer treatment demonstrates his commitment to improving patient outcomes. Through his patents and collaborations, he continues to influence the pharmaceutical landscape, driving advancements that hold promise for addressing complex health challenges faced by many.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile